Our laboratory is elucidating the nature of the immune response to tumors and establishing principles which may enhance our ability to immunize patients against known tumor antigens and induce tumor regression with cytokine therapy. We have developed methodologies for identifying tumor-specific CTL from patients with renal cell cancer and successfully used these techniques to identify unmutated FGF-5 as an HLA-A3 restricted antigen on RCC, recognized by T-cells. There is now an active clinical protocol immunizing patients with RCC with peptides from FGF-5. Continuing these efforts looking at other antigens expressed on RCC, we have found tumor-reactive T-cells in patients with RCC which recognize their own tumors as well as allogeneic RCCs. Some of these cells have unusual reactivity profiles and novel recognition mechanisms tumors. We are studying a CD4 clone that recognizes nearly all RCC regardless of classical MHC type yet utilizes the T-cell receptor. This class of T-cells could be a valuable reagent for addressing tumors which have lost MHC expression. Finally, we have also activated a protocol in which patients will be treated with their RCC-reactive T-cells discovered through these efforts.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC006660-22
Application #
7331264
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
Project End
Budget Start
Budget End
Support Year
22
Fiscal Year
2006
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wang, Qiong J; Yu, Zhiya; Hanada, Ken-Ichi et al. (2017) Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers. Clin Cancer Res 23:2267-2276
Ilyas, Sadia; Yang, James C (2015) Landscape of Tumor Antigens in T Cell Immunotherapy. J Immunol 195:5117-22
Wang, Qiong J; Hanada, Ken-Ichi; Yang, James C (2008) Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas. J Immunol 181:3769-76
Beck, Kimberly E; Blansfield, Joseph A; Tran, Khoi Q et al. (2006) Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 24:2283-9
Hanada, Ken-Ichi; Yewdell, Jonathan W; Yang, James C (2004) Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427:252-6